
Atox Bio
Get Full AccessDescription
- Atox Bio is a late stage biotechnology company that develops novel immunomodulators to treat critically ill patients. Initial focus is on patients with Necrotizing Soft Tissue Infections (flesh eating bacteria), a rare, life threatening, infection for which no current therapy exists. AB103, the companys lead product, is studied in ACCUTE (AB103 Clinical Composite endpoint StUdy in necrotizing soft Tissue InfEctions), a phase 3 clinical trial. AB103 received Orphan Drug designation from the FDA and EMA and Fast Track designation from the FDA.
-
Headquarters:1000 Park Forty Plaza , Durham, North Carolina, United States
More -
Phone Number:
-
Website: https://www.atoxbio.com
-
Employees:30
-
Revenue:$10 - 50M
-
Legal Name:Atox Bio
-
Atox Bio's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Atox Bio
-
Where are Atox Bio's Headquarters?
Atox Bio's Headquarters are in 1000 Park Forty Plaza ,Durham,North Carolina,United States
-
What is Atox Bio's official website?
Atox Bio's official website is https://www.atoxbio.com
-
What is Atox Bio's Revenue?
Atox Bio's revenue is $10 - 50M
-
What is Atox Bio's NAICS code?
Atox Bio's NAICS code is 541713
-
How many employees are working in Atox Bio
Atox Bio has 30 employees
-
What is Atox Bio's Industry?
Atox Bio is in the industry of Biotechnology
-
Who is Atox Bio's CEO?
Atox Bio's CEO is Dan Teleman
-
Who is Atox Bio's Chief Medical Officer?
Atox Bio's Chief Medical Officer is Wayne Dankner